Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
Clinical trial NCT01170286 · COMPLETED
Trial details
- NCT number
- NCT01170286
- Sponsor
- DBV Technologies
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2012-02-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.